arBtrage CAPITALIZING MARKETS checking… Sign in

Halozyme Therapeutics, Inc.

HALO Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$71.53
▼ -0.1% Today
as of Jun 7, 07:16 ET
Last 30 days +12.01% Apr 28 → Jun 05
$62.38 $64.85 $67.33 $69.81 $72.28 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$71.73
High
$72.25
Low
$70.71
Volume
$1M
Avg Vol
$2M
Mkt Cap
$8.1B
P/E (TTM)
17.97
Beta
52w High
$82.22
52w Low
$51.06
Div Yield
Shares Out
$119M

Overview

52-week range
$51
$82
66% of range
Avg surprise (last 2)
+8.6%
Avg reaction (last 2)
+0.8%
50% positive
Latest IV / EM
36%
EM ±5.0% · $70 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.56$0.79$1.02$1.25$1.48 Actual $0.56Actual $0.61Actual $0.60Actual $0.72Actual $1.05Actual $1.03Est $0.89Actual $1.33Actual $1.43Actual $1.48Est $1.46 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$0$46M$92M$138M$184M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $1.48 $1.46 +1.4% +43.7% +3.6% earnings
Tue Sep 30, 2025Sep 2025 $1.43 financials
Mon Jun 30, 2025Jun 2025 $1.33 financials
Tue May 6, 2025Mar/2025 $1.03 $0.89 +15.7% -2.0% earnings
Mon Sep 30, 2024Sep 2024 $1.05 financials
Sun Jun 30, 2024Jun 2024 $0.72 financials
Sun Mar 31, 2024Mar 2024 $0.60 financials
Sat Sep 30, 2023Sep 2023 $0.61 financials
Fri Jun 30, 2023Jun 2023 $0.56 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$79M$55M$46M$48M$49M$40M
Gross profit
Operating income$185M$218M$202M$142M$163M$117M
Net income$150M$175M$165M$118M$137M$93M
EPS (diluted)$1.22$1.43$1.33$0.93$1.05$0.72

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$310M$134M$420M$62M$176M$116M$154M$188M
Inventory$155M$176M$186M$182M$165M$142M$131M$159M
Total current assets$1.00B$825M$1.33B$1.12B$1.26B$1.09B$1.13B$988M
Total assets$2.67B$2.53B$2.22B$2.05B$2.20B$2.06B$2.12B$1.97B
Long-term debt$1.94B$2.14B$800M$1.51B$1.51B$1.51B$1.50B$1.50B
Total liabilities$2.45B$2.48B$1.72B$1.72B$1.71B$1.70B$1.67B$1.68B
Total equity$220M$49M$504M$333M$482M$364M$453M$289M

Implied volatility — last 90 days

31%33%36%38%41% Jun 07 — IV 36% · EM ±5.0%

Sector peers